A Long-term Efficacy Assessment Following Initial Scar Revision Surgery And Phase 2 Open-label Study To Evaluate Safety Of Re-treatment With Pf-06473871

Trial Profile

A Long-term Efficacy Assessment Following Initial Scar Revision Surgery And Phase 2 Open-label Study To Evaluate Safety Of Re-treatment With Pf-06473871

Discontinued
Phase of Trial: Phase II

Latest Information Update: 17 Feb 2016

At a glance

  • Drugs PF 6473871 (Primary)
  • Indications Hypertrophic scars
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 26 Jan 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 17 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
    • 24 Nov 2014 Planned End Date changed from 1 Nov 2015 to 1 Oct 2015 according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top